RecruitingPhase 2NCT07334912

AEF0217 in Participants With Down Syndrome

Studying Down syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Aelis Farma
Principal Investigator
Pier Vincenzo PIAZZA, MD, PhD
Aelis Farma
Intervention
AEF0217 100 µg(drug)
Enrollment
188 enrolled
Eligibility
16-32 years · All sexes
Timeline
20252027

Study locations (10)

Collaborators

European Commission · BioClever 2005 S.L. · Eurofins ADME, S.L. · Pharmalex · Hospital del Mar Research Institute (IMIM)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07334912 on ClinicalTrials.gov

Other trials for Down syndrome

Additional recruiting or active studies for the same condition.

See all trials for Down syndrome

← Back to all trials